Immunology Case Reports

About The Journal Open Access

Immunology Case Reports

Immunology Case Reports is a Peer reviewed medical journal that includes a wide range of fields in its discipline to create a platform for the authors to make their contributions towards the journal. The editorial office promises a thorough peer review of the submitted manuscripts to maintain quality.

Aims and Scope

Immunology Case Reports that aims to publish the most complete and reliable source of information on discoveries and current developments in the field as original articles, review articles, case reports, short communications and making them available online without any restrictions or subscriptions to the researchers worldwide. The journal is using Editorial Manager System for quality in the review process.

Immunology Case Reports is the unique platform for discussion that covers the topics such as ImmunologyImmunity, Immune System, Immune Disorder, Cell Mediated Immune Disorder, immune system boosters, Tumor Immunology, Immune mechanisms and its evolution, Theoretical approaches of Immune System. Focus of the high impact factor journal is the disease process explanation and organization procedures ensuring in enhanced outcomes for the patient. Patient perspective satisfaction, healthy life, quality treatment, communication and health literacy and their role in developing new health care programs and clinical outcomes are major areas of interest for this journal.

Immunology Case Reports is using Tracking System for easy online tracking and managing of the manuscript processing. Each article undergoes a peer review process under the aegis of an assigned Editor.

You may submit manuscripts online at www.editorialmanager.com/scholarlyjournals/ or you may send the article as an email attachment to [email protected] or [email protected] or  i[email protected]

Please submit your manuscript to
[email protected]

Just Published Articles

Review Article August 31, 2017

P.31-35

Immune Syst Disord J: 1(2): 31-35

What do we know about cancer immunotherapy? Long-term survival and immune-related adverse events

D errico G, Miranda J, Ostios L, Villamayor J

Review Article August 01, 2017

P.17-19

Immune Syst Disord J: 1(2): 17-19

Esquisse of the epidemiological scenario of chagas disease in Brazil.

Brasileiro MR

Short Communication June 14, 2017

P.27-30

Immune Syst Disord J: 1(2): 27-30

Human visceral leishmaniosis: Epidemiological analysis of the Brazilian territory.

Brasileiro MR

Review Article June 08, 2017

P.20-26

Immune Syst Disord J: 1(2): 20-26

Harnessing the Immune Regulatory Balance of Toll-like Receptor 9 Agonists in Cancer Immunotherapy.

Cui J, Bai L, Zhou L, Chen W, Chen J